Advisors Asset Management, Inc. Astrazeneca PLC Transaction History

Advisors Asset Management, Inc.

$5.23 Billion
Q4 2024

A detailed history of Advisors Asset Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 43,116 shares of AZN stock, worth $3.17 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

43,116

Previous 54,928 21.5%

Holding current value

$3.17 Million

Previous $4.28 Million 34.0%

% of portfolio

0.05%

Previous 0.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$63.2 - $79.58 $746,518 - $939,998	-11,812 Reduced 21.5%	43,116 $2.82 Million
Q3 2024 Nov 08, 2024	SELL	$76.67 - $87.62 $82,343 - $94,103	-1,074 Reduced 1.92%	54,928 $4.28 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $297,504 - $359,935	-4,453 Reduced 7.37%	56,002 $4.37 Million
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $233,805 - $266,522	3,831 Added 6.77%	60,455 $4.1 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $350,668 - $392,540	5,666 Added 11.12%	56,624 $3.81 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $350,319 - $379,883	-5,011 Reduced 8.95%	50,958 $3.65 Million
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $193,617 - $219,525	3,066 Added 5.8%	55,969 $3.88 Million
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $211,039 - $274,222	3,893 Added 7.94%	52,903 $3.59 Million
Q3 2022 Nov 08, 2022	BUY	$53.02 - $135.75 $37,220 - $95,296	702 Added 1.45%	49,010 $2.69 Million
Q2 2022 Aug 08, 2022	SELL	$59.26 - $71.14 $996,279 - $1.2 Million	-16,812 Reduced 25.82%	48,308 $3.19 Million
Q1 2022 May 17, 2022	SELL	$55.72 - $67.12 $571,687 - $688,651	-10,260 Reduced 13.61%	65,120 $4.32 Million
Q4 2021 Feb 15, 2022	SELL	$54.02 - $63.83 $235,797 - $278,617	-4,365 Reduced 5.47%	75,380 $4.39 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $832,677 - $911,059	14,987 Added 23.14%	79,745 $4.79 Million
Q2 2021 Jul 30, 2021	BUY	$48.42 - $60.18 $166,032 - $206,357	3,429 Added 5.59%	64,758 $3.88 Million
Q1 2021 May 07, 2021	SELL	$47.16 - $54.44 $384,636 - $444,012	-8,156 Reduced 11.74%	61,329 $3.05 Million
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $87,530 - $104,668	-1,804 Reduced 2.53%	69,485 $3.47 Million
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $282,173 - $324,868	5,317 Added 8.06%	71,289 $3.91 Million
Q2 2020 Aug 12, 2020	SELL	$43.1 - $55.31 $301,829 - $387,335	-7,003 Reduced 9.6%	65,972 $3.49 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $259,768 - $352,842	-6,874 Reduced 8.61%	72,975 $3.26 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $76,215 - $90,575	-1,795 Reduced 2.2%	79,849 $3.98 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $25,195 - $28,555	-628 Reduced 0.76%	81,644 $3.64 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $76,051 - $85,027	2,040 Added 2.54%	82,272 $3.4 Million
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $400,824 - $485,867	11,294 Added 16.38%	80,232 $3.24 Million
Q4 2018 Jan 31, 2019	SELL	$36.86 - $41.49 $275,491 - $310,096	-7,474 Reduced 9.78%	68,938 $2.62 Million
Q3 2018 Nov 15, 2018	SELL	$34.76 - $39.72 $269,181 - $307,591	-7,744 Reduced 9.2%	76,412 $3.02 Million
Q2 2018 Aug 22, 2018	BUY	$34.55 - $37.05 $2.49 Million - $2.68 Million	72,212 Added 604.59%	84,156 $2.96 Million
Q2 2018 Aug 15, 2018	SELL	$34.55 - $37.05 $2.67 Million - $2.86 Million	-77,278 Reduced 86.61%	11,944 $2.96 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $121,362 - $134,835	-3,681 Reduced 3.96%	89,222 $2.96 Million
Q4 2017 Feb 13, 2018	SELL	$32.09 - $34.78 $148,416 - $160,857	-4,625 Reduced 4.74%	92,903 $3.22 Million
Q3 2017 Nov 07, 2017	BUY	$28.96 - $34.0 $2.82 Million - $3.32 Million	97,528	97,528 $3.3 Million

Others Institutions Holding AZN

# of Institutions

1,351

Shares Held

489M

Call Options Held

5.88M

Put Options Held

4.1M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $228B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Astrazeneca PLC Transaction History